The U.S. FDA approved Teva Pharmaceutical Industries Ltd.'s Vantrela for pain.
The treatment is formulated with Teva's proprietary abuse-deterrent technology.
Discover more about S&P Global’s offerings
US FDA approves Teva Pharmaceutical's pain medication
Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022
Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes
The U.S. FDA approved Teva Pharmaceutical Industries Ltd.'s Vantrela for pain.
The treatment is formulated with Teva's proprietary abuse-deterrent technology.